Corporate Governance

The Matoke Holdings™ Management Board is comprised of senior figures from the business and medical communities.

Ian Staples

Chief Executive and Founder

Ian Staples is chief executive and founder of Matoke Holdings™. Ian is an entrepreneur who graduated from the University of Reading with a first class honours degree in horticultural science (plant physiology). His working career saw him open a series of garden centres before becoming managing director of the retailer Halfords, operating across the UK and Ireland. During Ian’s period at the helm, turnover grew from just over £100m to £300m.

Whilst living on a farm in the Lakes Region of Southern Chile with his wife, Ian observed that nectar in the hive never fermented. This discovery prompted Ian to work with leading scientists and led to the invention of Reactive Oxygen and the establishment of Matoke Holdings Ltd.

Brian McGowan


Brian McGowan is the Chairman of Matoke Holdings™, bringing a wealth of business experience to drive forward the business’ expansion.

Brian co-founded Williams Holdings in 1982, which became one of the most successful companies of the 1980s and 1990s and included businesses such as Crown Paints, Polycell, Cuprinol, Kidde, Chubb, Thorn and Yale. After retiring from Williams in 1993 he became Chairman at House of Fraser plc, Rentokil plc, Umeco plc and Catalyst Corporate Finance.

Dr Matthew Dryden

Chief Scientific Adviser

Dr Matthew Dryden (MD FRCPath FRCPS (Glasgow)) is Chief Scientific Adviser at Matoke Holdings™. Having been behind much of the initial laboratory work, he was the first to clinically use Reactive Oxygen to treat patients. As well as Reactive Oxygen, his research interests have been in staphylococcal infection, skin and soft tissue infection, the development of new antibiotics, antibiotic stewardship, the management of MRSA infections, and Lyme disease in the UK, and he has published and presented more than 100 papers in these fields.

In addition to his role at Matoke, Dr Dryden is a clinical director of infection the Hampshire Hospitals NHS Foundation Trust, and at the Rare and Imported Pathogens Department, Public Health England. He is also an honorary senior lecturer at Southampton University Medical School and a member of the medical department faculty at St George’s University School of Medicine in Grenada, West Indies. He is a consultant to the Falkland Islands and St Helena Governments’ Health Services.

Dr Dryden trained at Oxford University and St Thomas’ Hospital, London, and qualified in medicine. Dr Dryden was General Secretary of the British Society for Antimicrobial Chemotherapy. He is a member of the British Medical Association, the British Infection Society, the Hospital Infection Society, and a Fellow of the Royal Geographical Society and the Royal College of Pathologists and the Royal College of Physicians and Surgeons of Glasgow. He has worked in Sierra Leone for the British response to the Ebola outbreak.

Professor Jonathan Cooke

Chief Pharmaceutical Adviser

Professor Jonathan Cooke (BPharm, MPharm, PhD, FRPharmS) is Chief Pharmaceutical Adviser at Matoke Holdings™ as well as a Professor of Infectious Diseases at Manchester University Pharmacy School and Imperial College London Department of Medicine. He collaborated on much of the early cutting-edge research on Reactive Oxygen and is the author of a number of theoretical papers into the science behind it.

Professor Cooke has spent over 35 years in the NHS including the position of Director of Research and Development and Director of Medicines Management at the University Hospital of South Manchester. He is Honorary Professor, Manchester Pharmacy School, University of Manchester and Visiting Professor, Department of Medicine, Imperial College London. Has a specialist interest in antimicrobial resistance and was member of the UK Department of Health’s Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI), Chair of the Antimicrobial Stewardship Committee and Advisor to WHO. He was also a member of the Department of Health’s Clostridium difficile Guidelines Working Party, Trustee and Director of the Fungal Infection Trust, and member of the All Party Parliamentary Group on Patient Safety.

Andy Currie

Non-Executive Director

Andy is a Non-Executive Director of Matoke Holdings™ and is Managing Partner of Catalyst Corporate Finance.

With a corporate finance career spanning over 25 years, Andy provides him particular knowledge and expertise of Human Capital businesses, such as consultancies and professional services firms, and of advising private equity, bank consortia and other complex shareholder structures.

An alumnus of Leicester University, Andy qualified as a Chartered Accountant with Price Waterhouse, (now PwC) and had a spell in industry with a listed building services firm prior to the formation of Catalyst in 1998.

The Chief Executive’s Office is comprised of an expert team supporting the strategic direction of Matoke Holdings™.

Wendy Richings Barrow

Regulatory Adviser

Wendy Richings Barrow is Matoke’s Regulatory Adviser, helping to navigate Reactive Oxygen technology medicinal products through the regulatory process to fully approved and accredited products. Wendy provides regulatory, scientific and project management services to Matoke. She brings a broad range of experience as Founder of Subiaco Associates, having worked with start-up companies developing orphan drugs to multi-national companies. Prior to establishing Subiaco, Wendy was Licensing & Acquisition Manager at Lederle Laboratories and Regulatory Affairs Manager for Cyanamid of Great Britain’s human pharmaceutical and medical device companies.

Ian Jenkins

Company Secretary & Legal Counsel

Ian Jenkins, is Matoke’s Legal Counsel, and was the Senior Partner for 13 years of a City firm of solicitors with offices in London, Hong Kong and Shanghai. He also served as a non-executive director of a number of client companies, both public and private.

Chris Mottram

Chief Financial Officer

Chris Mottram (ACA) is Chief Financial Officer of Matoke Holdings™. He is a Senior Executive with extensive global experience working within a major multinational corporation, the Coca-Cola Company. He ensures that Matoke maintains operational excellence and a business focus.

Paul Thompson

Research Grant Lead

Paul Thompson leads on pursuing research grants for Matoke Holdings™. He is an Aeronautics & Astronautics graduate from the University of Southampton and initially researched helicopter performance for the Ministry of Defence. Paul has extensive experience of the design and delivery of information systems and founded a software consultancy business. He has spent some 30 years working in the defence sector where he was Technical Director of the Niteworks Partnership and a senior executive at BAE Systems, but now focuses his efforts on working with technology startups and universities, helping to commercialise innovative technologies. This work typically involves the identification and development of appropriate business strategies and very often requires grant funding to allow startups and SMEs to accelerate the development of their innovations and bring new products and services to market.